Nottinghamshire, United Kingdom

Hanae Benelkebir

This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Receptos, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hanae Benelkebir. Retrieved from https://idiyas.com/inventor/hanae-benelkebir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hanae Benelkebir

Introduction

Hanae Benelkebir is a notable inventor based in Nottinghamshire, GB. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on receptor agonists. Her dedication to research and development has led to advancements that could impact various therapeutic areas.

Latest Patents

Hanae holds a patent for CXCR3 receptor agonists. This patent includes compounds that possess a specific structure defined in her work. The pharmaceutical compositions derived from these compounds, along with methods related to their manufacture and use, showcase her expertise and innovative approach in the field.

Career Highlights

Hanae is currently associated with Receptos, Inc., where she continues to push the boundaries of pharmaceutical research. Her work has not only contributed to her personal achievements but has also enhanced the capabilities of her organization in developing new therapeutic solutions.

Collaborations

Hanae has collaborated with esteemed colleagues such as Adam Richard Yeager and Philip Turnbull. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hanae Benelkebir's contributions to the field of pharmaceuticals through her patent on CXCR3 receptor agonists exemplify her commitment to innovation. Her work continues to inspire and pave the way for future advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…